Krispy Kreme
DNUT
2.92
-0.10
-3.31%
Krispy Kreme
US · DNUT
#3744 by market cap
Listed 2021
2.92
-0.10
-3.31%
Live - 5344 symbols - heartbeat 218s ago
· 2026-10-08 09:14
Pre-market
2.94
+0.80%
After-hours
2.95
+1.00%
Overnight
2.94
+0.68%
- Market cap
- 506.62M
- P/E (TTM)i
- -5.31
- P/Bi
- 0.82
- EPSi
- -3.04
- Div yieldi
- 0.00%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on DNUT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.13, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.57% YoY
Margins
- Gross margin
- 75.53%
- Operating margin
- -2.19%
- Net margin
- -34.16%
Key ratios & quality
- Enterprise valuei
- 1.49B
- Altman Z-Scorei
- 0.13
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 795.88M | 959.41M | 1.12B | 1.38B | 1.53B | 1.69B | 1.67B | 1.52B |
| Gross profit | 549.43M | 697.40M | 811.13M | 1.03B | 1.12B | 1.24B | 1.26B | 1.15B |
| Selling & admin expenses | 160.93M | 190.24M | 216.32M | 261.88M | 265.76M | 312.74M | 322.00M | 271.34M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 43.08M | 52.54M | 15.86M | 46.67M | 33.20M | 42.17M | -860.00K | -33.27M |
| Pretax profit | -17.76M | -21.42M | -51.83M | -4.10M | -8.16M | -40.99M | 19.77M | -544.60M |
| Tax | -5.32M | 12.58M | 9.11M | 10.75M | 612.00K | -4.35M | 15.95M | -20.82M |
| Net profit | -12.44M | -34.00M | -60.94M | -14.84M | -8.78M | -36.65M | 3.82M | -523.78M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 |
| Diluted EPS | -0.09 | -0.23 | -0.41 | -0.18 | -0.10 | -0.23 | 0.02 | -3.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 375.18M | 379.77M | 375.30M | 392.37M | 367.03M | 331.00M |
| Gross profit | 284.45M | 287.14M | 279.08M | 299.38M | 278.70M | 244.96M |
| Selling & admin expenses | 69.64M | 75.11M | 61.19M | 65.41M | 68.15M | 64.78M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -19.18M | -26.15M | -1.71M | 13.76M | -10.43M | -6.74M |
| Pretax profit | -36.07M | -461.57M | -22.95M | -24.01M | -19.09M | -24.09M |
| Tax | -2.67M | -20.45M | -2.82M | 5.12M | 3.58M | -4.26M |
| Net profit | -33.41M | -441.12M | -20.13M | -29.13M | -22.67M | -19.83M |
| Basic EPS | 0 | -3 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.22 | -2.55 | -0.11 | -0.17 | -0.16 | -0.12 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 117.87M | 164.09M | 156.90M | 178.27M | 173.58M | 172.94M | 174.45M |
| Cash & ST investments | -- | 37.40M | 38.51M | 38.56M | 35.37M | 38.19M | 28.96M | 42.39M |
| Inventory | -- | 22.56M | 38.52M | 34.85M | 46.24M | 34.72M | 28.13M | 26.88M |
| Total assets | -- | 2.87B | 3.06B | 3.15B | 3.15B | 3.24B | 3.07B | 2.59B |
| Total current liabilities | -- | 382.50M | 497.84M | 526.16M | 516.47M | 525.59M | 486.17M | 457.28M |
| Short-term debt | -- | 93.30M | 86.92M | 86.94M | 83.19M | 105.00M | 102.98M | 117.19M |
| Long-term debt | -- | 1.05B | 1.13B | 680.31M | 739.05M | 836.62M | 844.55M | 911.85M |
| Total liabilities | -- | 1,991,209,000.00 | 2,212,636,000.00 | 1,809,599,000.00 | 1,849,662,000.00 | 1,976,809,000.00 | 1,934,895,000.00 | 1,940,179,000.00 |
| Total equity | -- | 883.42M | 848.36M | 1.34B | 1.30B | 1.26B | 1.14B | 652.78M |
| Retained earnings | -- | -77.88M | -142.20M | -178.41M | -217.49M | -278.99M | -299.64M | -821.39M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 157.99M | 154.56M | 161.79M | 174.45M | 186.86M | 165.42M |
| Cash & ST investments | 18.72M | 21.26M | 30.71M | 42.39M | 74.22M | 21.83M |
| Inventory | 31.52M | 33.70M | 28.08M | 26.88M | 27.22M | 28.67M |
| Total assets | 3.09B | 2.63B | 2.60B | 2.59B | 2.39B | 2.36B |
| Total current liabilities | 449.46M | 457.61M | 448.93M | 457.28M | 445.97M | 465.12M |
| Short-term debt | 105.52M | 114.58M | 121.00M | 117.19M | 103.46M | 117.99M |
| Long-term debt | 858.94M | 470.05M | 495.68M | 911.85M | 829.65M | 794.21M |
| Total liabilities | 1,957,906,000.00 | 1,912,285,000.00 | 1,906,003,000.00 | 1,940,179,000.00 | 1,753,292,000.00 | 1,743,544,000.00 |
| Total equity | 1.13B | 718.19M | 693.84M | 652.78M | 633.26M | 619.78M |
| Retained earnings | -338.89M | -774.16M | -793.61M | -821.39M | -844.17M | -864.48M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 148.34M | 80.81M | 28.68M | 141.22M | 139.82M | 45.54M | 45.83M | 33.92M |
| Depreciation & amortization | 49.45M | 63.77M | 80.40M | 101.61M | 110.26M | 125.89M | 133.60M | 137.07M |
| Free cash flow | 105.50M | 4.44M | -69.15M | 21.73M | 28.10M | -75.88M | -74.96M | -64.01M |
| Dividends paid | -29.84M | -2.63M | -42.00K | -48.19M | -23.43M | -23.56M | -23.69M | -11.93M |
| Stock buybacks / issuance | -- | 0 | 0 | 508.76M | -4.31M | -1.12M | -4.57M | -1.35M |
| Ending cash balance | 53.11M | 35.45M | 37.48M | 39.19M | 35.73M | 38.61M | 29.32M | 42.89M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -20.83M | -32.54M | 42.28M | 45.02M | 20.17M | -10.21M |
| Depreciation & amortization | 33.90M | 35.78M | 33.45M | 33.95M | 32.12M | 27.01M |
| Free cash flow | -46.73M | -60.75M | 15.54M | 27.93M | 11.38M | -17.52M |
| Dividends paid | -5.96M | -5.97M | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -123.00K | -664.00K | -397.00K | -166.00K | -272.00K | 7.00K |
| Ending cash balance | 19.17M | 21.82M | 31.15M | 42.89M | 74.71M | 22.14M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -5.09 | -7.06 | -2.56 | -1.32 | -3.21 | 0.27 | -58.28 |
| ROA %i | -- | -1.30 | -1.69 | -0.79 | -0.51 | -1.19 | 0.10 | -18.36 |
| ROIC %i | -- | 0.29 | -0.37 | 0.40 | 0.45 | 0.28 | 2.00 | -20.02 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -4.29 | -3.22 | -13.05 |
| EBIT margin %i | 3.65 | 4.02 | 0.48 | 2.81 | 1.70 | 0.55 | 4.79 | -31.45 |
| FCF / sales %i | 13.26 | 0.46 | -- | 1.57 | 1.84 | -- | -- | -- |
| Current ratioi | -- | 0.31 | 0.33 | 0.30 | 0.35 | 0.33 | 0.36 | 0.38 |
| Quick ratioi | -- | 0.22 | 0.23 | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 |
| Debt / assetsi | -- | 52.25 | 52.06 | 37.60 | 39.22 | 43.08 | 44.04 | 54.95 |
| LT debt / equityi | -- | 191.72 | 220.03 | 88.95 | 96.28 | 110.39 | 110.17 | 201.15 |
| Interest coveragei | 0.62 | 0.64 | 0.09 | 0.90 | 0.76 | 0.19 | 1.33 | -7.28 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 20.26 | 16.83 | 14.54 | 6.35 | -0.16 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -40.95 | 84.99 | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.92 | -49.36 | -55.18 | -58.28 | -58.92 | -14.43 |
| ROA %i | -0.68 | -15.42 | -18.02 | -18.36 | -18.65 | -3.79 |
| ROIC %i | 1.08 | -16.45 | -19.55 | -20.02 | -20.06 | -2.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.04 | -26.13 | -31.30 | -31.45 | -30.53 | -1.93 |
| FCF / sales %i | -- | -- | -- | -- | -- | 2.55 |
| Current ratioi | 0.35 | 0.34 | 0.36 | 0.38 | 0.42 | 0.36 |
| Quick ratioi | 0.23 | 0.21 | 0.23 | 0.25 | 0.31 | 0.24 |
| Debt / assetsi | 46.96 | 54.11 | 55.30 | 54.95 | 53.40 | 53.45 |
| LT debt / equityi | 122.11 | 188.70 | 196.45 | 201.15 | 185.34 | 185.30 |
| Interest coveragei | 0.78 | -6.21 | -7.41 | -7.28 | -7.09 | -0.46 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- US is the largest reported line at 52.17% of revenue, across 3 reported segments.
- International follows at 35.45%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
US52.17%
International35.45%
Market Development12.38%
Quote time 2026-10-08 09:14:33 · For reference only, not investment advice and not tailored to your situation.